Filter By Category
Archives
Share on -
ECNOGLUTIDE
Generic Name: ECNOGLUTIDE
ABSTRACT -
Ecnoglutide is a GLP-1 receptor agonist peptide investigated for glycemic control and weight-management indications. Peptide sequence and formulation define its molecular properties.
DOSAGE -
Usually administered by subcutaneous injection on a protocol-specific schedule. Titration is commonly used for incretin therapies to improve gastrointestinal tolerability.
SIDE EEFECTS -
- Nausea, vomiting, diarrhea, constipation, or abdominal pain
- Reduced appetite
- Injection-site reaction
- Hypoglycemia when combined with insulin or sulfonylureas
- Gallbladder-related symptoms
ALLERGIC REACTIONS -
These symptoms may indicate an allergic reaction and require medical attention.
- Rash, urticaria, angioedema, or anaphylaxis
- Severe abdominal pain may also require urgent evaluation
DRUG INTERACTIONS-
- May delay gastric emptying and affect absorption of oral medicines
- Insulin or sulfonylureas may increase hypoglycemia risk
- Use caution with drugs requiring rapid gastrointestinal absorption
PREAUTONS–
- Assess pancreatitis history, gallbladder disease, renal function during dehydration, and pregnancy status
- Educate on severe abdominal symptoms and hydration
WARNINGS –
- Potential pancreatitis, gallbladder disease, and serious hypersensitivity risk
- Do not substitute with other GLP-1 products without guidance
Share on -
. Developed by